157 related articles for article (PubMed ID: 32872745)
1. Association between the progression of immunoglobulin A nephropathy and a controlled status of hypertension in the first year after diagnosis.
Oh TR; Choi HS; Oh SW; Oh J; Lee DW; Kim CS; Ma SK; Kim SW; Bae EH;
Korean J Intern Med; 2022 Jan; 37(1):146-153. PubMed ID: 32872745
[TBL] [Abstract][Full Text] [Related]
2. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
Front Immunol; 2021; 12():700224. PubMed ID: 34456912
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking may accelerate the progression of IgA nephropathy.
Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
[TBL] [Abstract][Full Text] [Related]
4. Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy.
Shen Y; Xiao T; Yu Z; Huang Y; He T; Li H; Zhang J; Xiong J; Zhao J
Ren Fail; 2022 Dec; 44(1):994-1003. PubMed ID: 35658824
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
6. Association of obesity with the development of end stage renal disease in IgA nephropathy patients.
Wang S; Qin A; Dong L; Tan J; Zhou X; Qin W
Front Endocrinol (Lausanne); 2023; 14():1094534. PubMed ID: 37020590
[TBL] [Abstract][Full Text] [Related]
7. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
8. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
[TBL] [Abstract][Full Text] [Related]
10. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study.
Rehnberg J; Ludvigsson JF; Carrero JJ; Emilsson L
Nephrol Dial Transplant; 2022 Mar; 37(4):749-759. PubMed ID: 34788864
[TBL] [Abstract][Full Text] [Related]
12. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Hyperuricemia on the Prognosis of IgA Nephropathy are More Potent in Females.
Oh TR; Choi HS; Kim CS; Kang KP; Kwon YJ; Kim SG; Ma SK; Kim SW; Bae EH
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936416
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection.
Wang K; Yu Z; Huang Y; Yang K; He T; Xiao T; Yu Y; Li Y; Liu L; Xiong J; Zhao J
J Nephrol; 2021 Dec; 34(6):1887-1896. PubMed ID: 33683672
[TBL] [Abstract][Full Text] [Related]
17. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B
Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the albumin-to-fibrinogen ratio (AFR) in IgA nephropathy patients.
Qin A; Wang S; Dong L; Jiang Z; Yang D; Tan J; Tang Y; Qin W
Int Immunopharmacol; 2022 Dec; 113(Pt A):109324. PubMed ID: 36244218
[TBL] [Abstract][Full Text] [Related]
20. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]